At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Control Lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Success of Refitting Lens Wearers With MyDay Multifocal, Who Are Already Adapted to Clariti 1Day Multifocal 2-Add Design
In Brief
A clinical study evaluating Control Lens and Test Lens for Presbyopia. Completed, enrolled 60 participants across 5 sites.
Detailed Summary
The objective of the study was to adapt existing multifocal soft lens wearers to a Control Lens for at least 2 weeks and then evaluate the success of switching them to the Test Lens, with a review after 2 weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
CollaboratorsCentre for Ocular Research & Education, Canada
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartOct 2022
First PostedOct 2022
Primary CompletionFeb 2023
TodayJul 2026
First PostedOct 14, 2022
Enrollment StartOct 10, 2022
Primary CompletionFeb 7, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.7 years ago
Interventions
Control Lensdevice
Daily disposable multifocal soft lens with 2 add design (2ADD) for 2 weeks
Test Lensdevice
Daily disposable multifocal soft lens with 3 add design (3ADD) for 2 weeks